Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Alloy vs Corsica Health

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.4

Alloy

Best for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory
★★★3.7

Starting at $80/mo

Brand WegovyBrand ZepboundCompounded SemaglutideCompounded Tirzepatide
Visit Alloy
7.5

Corsica Health

Best for patients who want a single platform offering both compounded and brand-name GLP-1 options with publicly-disclosed pricing for direct comparison
★★★3.8

Starting at $299/mo

CompoundedBrand NameSemaglutideTirzepatide
Visit Corsica Health

Side-by-Side Comparison

FeatureAlloyCorsica Health
Overall Score7.4/107.5/10
Starting Price$80/mo$299/mo
Editorial Rating3.7 ★ /53.8 ★ /5
Features8 features9 features
States Available00
Compounded✓ Yes✓ Yes
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Alloy

Pros

  • Broadest GLP-1 formulary in our catalog: brand Wegovy + brand Zepbound + oral Wegovy + compounded semaglutide + compounded tirzepatide + compounded liraglutide
  • All consulting doctors are certified by The Menopause Society — only ~1,000 such certified practitioners exist among ~20,000 OB-GYNs in the US
  • Brand-name Wegovy starting at $199/mo and compounded liraglutide starting at $80/mo cover both ends of the price/access spectrum
  • STARTGLP1 promo code knocks $50 off the first month per the public site

Cons

  • Not available in Louisiana or Mississippi (verified) — readers in those two states should be routed elsewhere
  • Initial consultation is $49 and is separate from medication cost — readers should know there's a non-refundable upfront fee
  • Menopause-specialty framing — best fit for women in menopause/perimenopause, not the right product for men or younger women whose primary need is weight loss

Corsica Health

Pros

  • Public pricing disclosure for BOTH compounded and brand-name SKUs on marketing site — material YMYL transparency advantage vs peers
  • $299/month compounded semaglutide and $399/month compounded tirzepatide are in the median range for compounded telehealth
  • $1,499/month brand-name Wegovy/Ozempic/Mounjaro pricing is below typical retail cash-pay (~$1,300-$1,800)
  • LegitScript-approved seal displayed with verification link
  • Structured 3-step intake (Assessment → Provider Review → Receive Medication) clearly disclosed

Cons

  • Specific legal entity name + state of incorporation NOT publicly disclosed on the home page
  • Pharmacy partners described as 'licensed compounding pharmacy' but specific name NOT disclosed
  • Per-state availability NOT enumerated publicly
  • Zepbound and Foundayo NOT mentioned in the brand-name lineup (only Wegovy/Ozempic/Mounjaro)
  • First-month promotional pricing NOT disclosed (assumed steady-state from day one)
  • Lab work inclusion NOT clearly disclosed in marketing copy

Our Verdict

Winner: Corsica HealthScore: 7.5/10

Corsica Health edges out Alloy with a higher overall score of 7.5/10 and is particularly strong for patients who want a single platform offering both compounded and brand-name GLP-1 options with publicly-disclosed pricing for direct comparison. Alloy remains a solid alternative, especially if you're looking for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory.

Glossary references

Key terms in this article, linked to their canonical definitions.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.